id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2014-D-1814-0179,FDA,FDA-2014-D-1814,Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Other,Guidance,2019-10-02T04:00:00Z,2019,10,2019-10-02T04:00:00Z,,2024-11-12T23:09:28Z,,1,0,0900006484005149 FDA-2014-D-1814-0178,FDA,FDA-2014-D-1814,"Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services To Enhance the Safety and Availability of Platelets for Transfusion; Guidance for Industry; Availability",Notice,Notice of Data Availability,2019-10-02T04:00:00Z,2019,10,2019-10-02T04:00:00Z,,2019-10-02T13:42:50Z,2019-21228,0,0,09000064840036e4 FDA-2014-D-1814-0184,FDA,FDA-2014-D-1814,Reference 10 Bacterial Risk final guidance McDonald re: Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Supporting & Related Material,Background Material,2019-10-02T04:00:00Z,2019,10,,,2019-10-02T16:59:13Z,,0,0,0900006484005507 FDA-2014-D-1814-0180,FDA,FDA-2014-D-1814,References List re: Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Supporting & Related Material,Background Material,2019-10-02T04:00:00Z,2019,10,,,2019-10-02T16:57:42Z,,0,0,0900006484005501 FDA-2014-D-1814-0182,FDA,FDA-2014-D-1814,Reference 8 Bacterial Risk final guidance Haass re: Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Supporting & Related Material,Background Material,2019-10-02T04:00:00Z,2019,10,,,2019-10-02T17:00:16Z,,0,0,0900006484005505 FDA-2014-D-1814-0181,FDA,FDA-2014-D-1814,Reference 2 Bacterial Risk final guidance Fatalities Reported to FDA Annual Summary for FY2015 re: Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Supporting & Related Material,Background Material,2019-10-02T04:00:00Z,2019,10,,,2019-10-02T16:57:59Z,,0,0,0900006484005aef FDA-2014-D-1814-0183,FDA,FDA-2014-D-1814,Reference 9 Bacterial Risk final guidance Brecher re: Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion,Supporting & Related Material,Background Material,2019-10-02T04:00:00Z,2019,10,,,2019-10-02T17:00:58Z,,0,0,0900006484005506